|
US5077044A
(en)
|
1980-05-19 |
1991-12-31 |
The Board Of Trustees Of The Leland Stanford Jr. University |
Novel non-reverting shigella live vaccines
|
|
US5338683A
(en)
|
1981-12-24 |
1994-08-16 |
Health Research Incorporated |
Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
|
|
US5110587A
(en)
|
1981-12-24 |
1992-05-05 |
Health Research, Incorporated |
Immunogenic composition comprising synthetically modified vaccinia virus
|
|
US5174993A
(en)
|
1981-12-24 |
1992-12-29 |
Health Research Inc. |
Recombinant avipox virus and immunological use thereof
|
|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
|
US4945050A
(en)
|
1984-11-13 |
1990-07-31 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
US5036006A
(en)
|
1984-11-13 |
1991-07-30 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
GB8508845D0
(en)
|
1985-04-04 |
1985-05-09 |
Hoffmann La Roche |
Vaccinia dna
|
|
US5223424A
(en)
|
1985-09-06 |
1993-06-29 |
Prutech Research And Development |
Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence
|
|
US5310668A
(en)
|
1986-06-20 |
1994-05-10 |
Merck & Co., Inc. |
Varicella-zoster virus as a live recombinant vaccine
|
|
US5242829A
(en)
|
1986-09-23 |
1993-09-07 |
Therion Biologics Corporation |
Recombinant pseudorabies virus
|
|
US5387744A
(en)
|
1987-06-04 |
1995-02-07 |
Washington University |
Avirulent microbes and uses therefor: Salmonella typhi
|
|
IL86583A0
(en)
|
1987-06-04 |
1988-11-15 |
Molecular Eng Ass |
Vaccine containing a derivative of a microbe and method for the production thereof
|
|
US5294441A
(en)
|
1987-06-04 |
1994-03-15 |
Washington University |
Avirulent microbes and uses therefor: salmonella typhi
|
|
US5112749A
(en)
|
1987-10-02 |
1992-05-12 |
Praxis Biologics, Inc. |
Vaccines for the malaria circumsporozoite protein
|
|
US5225336A
(en)
|
1989-03-08 |
1993-07-06 |
Health Research Incorporated |
Recombinant poxvirus host range selection system
|
|
WO1990010693A1
(en)
|
1989-03-08 |
1990-09-20 |
Health Research, Inc. |
Recombinant poxvirus host selection system
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
ES2090129T3
(es)
|
1989-03-31 |
1996-10-16 |
Univ Washington |
Vacunas que contienen microorganismos tipo phop avirulentos.
|
|
EP0431668B1
(en)
|
1989-12-04 |
1995-02-15 |
Akzo Nobel N.V. |
Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
|
|
US5294548A
(en)
|
1990-04-02 |
1994-03-15 |
American Biogenetic Sciences, Inc |
Recombianant Hepatitis a virus
|
|
US5462734A
(en)
|
1990-11-02 |
1995-10-31 |
Wisconsin Alumni Research Foundation |
Bovine herpesvirus vaccine and method of using same
|
|
US5240703A
(en)
|
1991-03-01 |
1993-08-31 |
Syntro Corporation |
Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof
|
|
US5273525A
(en)
|
1992-08-13 |
1993-12-28 |
Btx Inc. |
Injection and electroporation apparatus for drug and gene delivery
|
|
US5593972A
(en)
|
1993-01-26 |
1997-01-14 |
The Wistar Institute |
Genetic immunization
|
|
US5981505A
(en)
|
1993-01-26 |
1999-11-09 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for delivery of genetic material
|
|
US5702359A
(en)
|
1995-06-06 |
1997-12-30 |
Genetronics, Inc. |
Needle electrodes for mediated delivery of drugs and genes
|
|
US5993434A
(en)
|
1993-04-01 |
1999-11-30 |
Genetronics, Inc. |
Method of treatment using electroporation mediated delivery of drugs and genes
|
|
US5439440A
(en)
|
1993-04-01 |
1995-08-08 |
Genetronics, Inc. |
Electroporation system with voltage control feedback for clinical applications
|
|
US5739118A
(en)
|
1994-04-01 |
1998-04-14 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
|
NL9401820A
(nl)
|
1994-11-02 |
1996-06-03 |
Meyn Maschf |
Inrichting voor het bewerken van aan zijn poten opgehangen gevogelte.
|
|
US5962428A
(en)
|
1995-03-30 |
1999-10-05 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
|
US5810762A
(en)
|
1995-04-10 |
1998-09-22 |
Genetronics, Inc. |
Electroporation system with voltage control feedback for clinical applications
|
|
US5739972A
(en)
|
1996-01-02 |
1998-04-14 |
Ibm |
Method and apparatus for positioning a magnetoresistive head using thermal response to servo information on the record medium
|
|
US6261281B1
(en)
|
1997-04-03 |
2001-07-17 |
Electrofect As |
Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
|
|
CA2285056C
(en)
|
1997-04-03 |
2004-12-14 |
Iacob Mathiesen |
Method for introducing pharmaceutical drugs and nucleic acids into skeletal muscle
|
|
AU8444798A
(en)
|
1997-06-30 |
1999-01-25 |
Centre National De La Recherche Scientifique |
Improved method for transferring nucleic acid into the striped muscle and combination therefor
|
|
US6241701B1
(en)
|
1997-08-01 |
2001-06-05 |
Genetronics, Inc. |
Apparatus for electroporation mediated delivery of drugs and genes
|
|
US6055453A
(en)
|
1997-08-01 |
2000-04-25 |
Genetronics, Inc. |
Apparatus for addressing needle array electrodes for electroporation therapy
|
|
US6216034B1
(en)
|
1997-08-01 |
2001-04-10 |
Genetronics, Inc. |
Method of programming an array of needle electrodes for electroporation therapy of tissue
|
|
US6135990A
(en)
|
1997-12-17 |
2000-10-24 |
University Of South Florida |
Electroporation device and method
|
|
US6778853B1
(en)
|
1997-12-17 |
2004-08-17 |
University Of South Florida |
Electroporation device
|
|
US6120493A
(en)
|
1998-01-27 |
2000-09-19 |
Genetronics, Inc. |
Method for the introduction of therapeutic agents utilizing an electroporation apparatus
|
|
AU3973599A
(en)
|
1998-05-08 |
1999-11-29 |
Genetronics, Inc. |
Electrically induced vessel vasodilation
|
|
US6678556B1
(en)
|
1998-07-13 |
2004-01-13 |
Genetronics, Inc. |
Electrical field therapy with reduced histopathological change in muscle
|
|
US6697669B2
(en)
|
1998-07-13 |
2004-02-24 |
Genetronics, Inc. |
Skin and muscle-targeted gene therapy by pulsed electrical field
|
|
SK4272001A3
(en)
*
|
1998-10-05 |
2003-02-04 |
Pharmexa As |
Methods for therapeutic vaccination
|
|
US20040241140A1
(en)
*
|
2000-11-01 |
2004-12-02 |
Pavlakis George N. |
Expression vectors able to elicit improved immune response and methods of using same
|
|
EP1633372B1
(en)
|
2003-06-13 |
2011-11-30 |
The Trustees of The University of Pennsylvania |
Vaccines, immunotherapeutics and methods for using the same
|
|
NZ570709A
(en)
|
2003-06-13 |
2010-04-30 |
Univ Pennsylvania |
Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
|
|
ES2367027T3
(es)
*
|
2004-02-27 |
2011-10-27 |
Inserm (Institut National De La Santé Et De La Recherche Medicale) |
Sitio de unión de la il-15 para il-15ralfa y mutantes específicos de il-15 que tienen actividad agonista/antagonista.
|
|
EP3263581B2
(en)
*
|
2005-05-17 |
2025-07-09 |
University of Connecticut |
Compositions and methods for immunomodulation in an organism
|
|
EP1777294A1
(en)
*
|
2005-10-20 |
2007-04-25 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
IL-15Ralpha sushi domain as a selective and potent enhancer of IL-15 action through IL-15Rbeta/gamma, and hyperagonist (IL15Ralpha sushi -IL15) fusion proteins
|
|
US20070160578A1
(en)
*
|
2005-12-14 |
2007-07-12 |
The Gov. Of The Usa As Represented By The Secretary Of The Dep. Of Health And Human Services |
Expansion of natural killer and CD8 T-cells with IL-15R/ligand activator complexes
|
|
NZ569541A
(en)
*
|
2006-01-13 |
2012-05-25 |
Us Gov Health & Human Serv |
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
|
|
CA3057039C
(en)
*
|
2006-07-28 |
2023-02-28 |
The Trustees Of The University Of Pennsylvania |
Hiv consensus envelope sequences and methods for using same
|
|
US20110020269A1
(en)
|
2007-05-08 |
2011-01-27 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for modifying t cell immune responses and inflammation
|
|
EP2048237A1
(en)
*
|
2007-10-05 |
2009-04-15 |
Avir Green Hills Biotechnology Research Development Trade Ag |
Replication deficient Influenza virus for the expression of heterologous sequences
|
|
NZ599338A
(en)
*
|
2007-06-27 |
2013-11-29 |
Marinepolymer Tech Inc |
Complexes of il-15 and il-15ralpha and uses thereof
|